![Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.](https://cdn.cancerletter.com/media/2024/01/02055719/40-36-carbon-ion-radiotherapy-research-and-treatment-facility-in-the-US.jpg)
![Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.](https://cdn.cancerletter.com/media/2024/01/02055719/40-36-carbon-ion-radiotherapy-research-and-treatment-facility-in-the-US.jpg)
Cover Story
The University of Colorado and Colorado State University are vying to become the first institution to build a carbon-ion radiotherapy research and treatment facility in the U.S. The treatment modality is available in Europe and Japan.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”